Children who are given antibiotics in their first three months often wheeze at 15 months of age. However, this wheezing is probably more due to the presence of chest infections than to the use of antibiotics.

A new paper by Shahriar Mobashery, Navari Family Professor in Life Sciences at the University of Notre Dame, and researchers in his lab provides important insights into promising new antibiotics aimed at combating MRSA.

A way to turn off one gene at a time has earned acceptance in biology laboratories over the last decade. Doctors envision the technique, called RNA interference, as a tool to treat a variety of diseases if it can be adapted to humans.

The problem with antibiotics is that, eventually, bacteria outsmart them and become resistant. But by targeting the gene that confers such resistance, a new drug may be able to finally outwit them.

An old intravenous antibiotic may have new life as a stroke treatment, researchers say.

A new study has found that swimming pools in remote Aboriginal communities can dramatically reduce rates of skin, ear and chest infections.

The American Society for Gastrointestinal Endoscopy (ASGE) has issued updated guidelines on antibiotic prophylaxis for gastrointestinal (GI) endoscopy based on the American Heart Association’s (AHA) recently revised guidelines for prophylaxis of infective endocarditis (IE). For endoscopic practice, the administration of prophylactic antibiotics solely to prevent IE is not recommended for patients who undergo GI-tract procedures.

Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer’s disease, Huntington’s disease, epilepsy, stroke, dementia and malignant gliomas.

Researchers at the University of Illinois at Chicago have discovered how some bacteria can survive antibiotic treatment by turning on resistance mechanisms when exposed to the drugs. The findings, published in the April 24 issue of the journal Molecular Cell, could lead to more effective antibiotics to treat a variety of infections.

A team led by Johns Hopkins researchers has solved important puzzles concerning how certain proteins guide the reproduction of bacteria, discoveries that could lead to a new type of antibiotics.

In a new development in antibiotics manufacturing industry alligators are emerging in a new role as potential lifesavers in medicine as alligator's blood may be a new source for making powerful antibiotics.

Bacteria are particularly harmful to human health when they band together to form a biofilm—a sheet composed of many individual bacteria glued together—because this can allow them to escape from both antibiotics and the immune system of their host.